June 06, 2018
In small pharmaceutical start-ups, you have to move fast with a limited amount of budget and resources to get your molecule to first-in-human, and then to proof-of-concept (POC). You keep headcount low and outsource wherever you can, often to multiple vendors. Working with multiple vendors means investing significant time to negotiate terms and conditions as well as to oversee the project.
Download this case study to learn how one small company took advantage of Thermo Fisher’s Quick to Care™ solution to streamline its drug development and expedite the path of molecule to commercial drug product.